Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology
The
complement system
complement system:
A group of proteins that move freely in the bloodstream.
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease
Patients with
paroxysmal nocturnal hemoglobinuria
paroxysmal nocturnal hemoglobinuria:
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs
The current standard of care for
paroxysmal nocturnal hemoglobinuria
paroxysmal nocturnal hemoglob
Clinical development of our investigational therapy, pegcetacoplan
Original Publication Date
Article Source
External Web Content
Dear members of the PNH community, We are excited to share important updates with you regarding the clinical development of our investigational therapy, pegcetacoplan, for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Since our last update, we have partnered with…
Pegcetacoplan Bests Eculizumab for PNH Patients
Original Publication Date
Article Source
External Web Content
Results from the phase III PEGASUS trial suggest that the targeted C3 inhibitor pegcetacoplan improved hemoglobin levels better than eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) who were still anemic despite at least three months of eculizumab therapy…
Clinical Challenges: Paroxysmal Nocturnal Hemoglobinuria — Complement inhibitors a major advance but not a cure
Original Publication Date
Article Source
External Web Content
Paroxysmal nocturnal hemoglobinuria (PNH) is an extremely rare, acquired, life-threatening disease of the blood. The name comes from one of the clinical consequences of the disease -- the breakdown of red blood cells and consequent release of hemoglobin into the urine. It often…
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease
In the UK, early work on paroxysmal nocturnal haemoglobinuria (PNH) was conducted by John Dacie who, at the Hammersmith Hospital, first hypothesised that the PNH abnormality might arise through a somatic mutation mutation:
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria: (pa
PNH - Traveling with a Rare Disease - Update from Josh
Traveling with a rare disease